| Unique ID issued by UMIN | UMIN000063702 |
|---|---|
| Receipt number | R000072899 |
| Scientific Title | Comparison of durability and running economy between running shoes with advanced footwear technology |
| Date of disclosure of the study information | 2026/11/19 |
| Last modified on | 2026/11/19 20:45:23 |
Comparison of durability and running economy between running shoes with advanced footwear technology
Comparison of durability and running economy between running shoes with advanced footwear technology
Comparison of durability and running economy between running shoes with advanced footwear technology
Comparison of durability and running economy between running shoes with advanced footwear technology
| Japan |
Healthy Subjects
| Adult |
Others
NO
To compare the efficacy of different advanced footwear technology shoes in attenuating the degradation of running economy during prolonged running.
Efficacy
Oxygen uptake drift rate
Oxygen uptake
Energy expenditure
Energy expenditure drift rate
Heart rate
Rating of perceived exertion
Perceived comfort
Interventional
Cross-over
Randomized
Individual
Open -no one is blinded
Active
2
Prevention
| Other |
Wearing test shoes
Wearing control shoes
| 18 | years-old | <= |
| 49 | years-old | > |
Male
Healthy males aged 18 to 48 years at the time of informed consent, with no history of serious illness.
Individuals with a personal best time of under 3 hours and 30 minutes in a full marathon completed in or after January 2024.
Individuals who run regularly at least 3 times a week.
Individuals currently undergoing treatment for any disease, or with a history of serious diseases requiring medication (e.g., cardiovascular, respiratory, or metabolic diseases).
Individuals with orthopedic complaints (e.g., joint pain, ligamentitis) or a history of trauma that would interfere with prolonged treadmill running.
Individuals who have sustained an injury within the past two months that interferes with running.
Individuals who routinely take medications or supplements that affect thermoregulation, cardiovascular function, or metabolism.
Current smokers.
Individuals with skin diseases or allergies that interfere with the wearing of measurement devices (e.g., respiratory gas analysis masks, heart rate monitors).
Others judged unsuitable for participation in this study by the principal investigator due to health conditions, safety concerns, or other reasons.
Employees of sports apparel and footwear-related companies (e.g., sporting goods manufacturers, agencies) or their family members.
Others judged by the principal investigator to have a significant conflict of interest regarding this study (and its funding source).
12
| 1st name | Fuminori |
| Middle name | |
| Last name | Takayama |
EUPHORIA Co., Ltd.
Corporate Business Division
102-0083
10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan
03-6388-9260
fuminori.takayama@eu-phoria.jp
| 1st name | Yuki |
| Middle name | |
| Last name | Urushizawa |
EUPHORIA Co., Ltd.
Corporate Business Division
102-0083
10th Floor, Crystal City East Building, 4-8-1 Kojimachi, Chiyoda-ku, Tokyo, Japan
03-6388-9260
yuki.urushizawa@eu-phoria.jp
EUPHORIA Co., Ltd.
Goldwin Inc.
Profit organization
Shiba Palace Clinic Ethics Review Committee
DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
03-5408-1599
shiba_palace@s-palace-clinic.com
NO
| 2026 | Year | 11 | Month | 19 | Day |
Unpublished
Preinitiation
| 2026 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 11 | Month | 20 | Day |
| 2027 | Year | 01 | Month | 31 | Day |
| 2026 | Year | 11 | Month | 19 | Day |
| 2026 | Year | 11 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072899